We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
252 hedge funds and large institutions have $2.03B invested in ADMA Biologics in 2024 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 88 increasing their positions, 84 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,302% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $527K
228% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 18
75% more capital invested
Capital invested by funds: $1.16B → $2.03B (+$871M)
18% more funds holding
Funds holding: 214 → 252 (+38)
1.41% more ownership
Funds ownership: 76.74% → 78.14% (+1.4%)
5% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 84
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
252
Holders Change
+38
Holders Change %
+17.76%
% of All Funds
3.64%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
59
Increased
88
Reduced
84
Closed
18
Calls
$12.7M
Puts
$527K
Net Calls
+$12.1M
Net Calls Change
+$9.19M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$45M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.3M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$13.4M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$30.7M |
| 2 |
State Street
Boston,
Massachusetts
|
-$20.9M |
| 3 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$13.4M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$13.1M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$12.9M |
